NCT03387111 2024-08-05
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
ImmunityBio, Inc.
Phase 1/2 Terminated
ImmunityBio, Inc.
Boston Scientific Corporation
Emory University
Japan Clinical Oncology Group
Stanford University
Hospital Authority, Hong Kong